4 completed. 4 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 4 |
| Phase 2 | 1 | Completed 1 |
Follow Thomas Hope: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| 18F-Fluorocholine Positron Emission Tomography (PET) for the Detection of Parathyroid Adenomas 18F-Fluorocholine, Positron emission tomography (PET) - Hyperparathyroidism, Primary | Phase 3 | Completed | Thomas Hope | 139 | 2021-06-30 | 2026-04-29 |
| Gallium-68 PSMA-11 PET Imaging in Prostate Cancer Patients Ga-68 labeled PSMA-11, Positron emission tomography-computed tomography (PET/CT), Positron emission tomography-magnetic resonance imaging (PET/MRI) - Prostate Cancer | Phase 3 | Completed | Thomas Hope | 485 | 2018-10-11 | 2021-08-24 |
| Gallium-68 PSMA-11 Positron Emission Tomography (PET) Imaging in Patients With Biochemical Recurrence Ga-68 labeled PSMA-11 PET - Prostate Cancer | Phase 3 | Completed | Thomas Hope | 346 | 2017-09-20 | 2021-10-21 |
| 18F-Fluorocholine for the Detection of Parathyroid Adenomas 18F-Fluorocholine, Positron Emission Tomography (PET) - Hyperparathyroidism, Primary | Phase 2 / Phase 3 | Completed | Thomas Hope | 98 | 2016-09-21 | 2021-10-19 |
Hyperparathyroidism, Primary (2) · Prostatic Neoplasms (2)
Magnetic Resonance Spectroscopy (2) · fluorocholine (2) · gallium 68 PSMA-11 (2) · Positron Emission Tomography Computed Tomography (1)
United States (4)